Mycoplasma suis (Eperythrozoonosis) in Pigs: Signs, Diagnosis, and Farm Control
A practical commercial-pig guide covering pathogen biology, clinical signs, diagnosis, treatment limits, farm prevention and relevant product support.
Problem Overview
Mycoplasma suis (Eperythrozoonosis) in Pigs: Signs, Diagnosis, and Farm Control addresses hemotropic Mycoplasma suis infection, historically called porcine eperythrozoonosis. Common field signs include pale skin, anemia, weakness, fever, reduced appetite, poor growth, jaundice, hypoglycemia or reproductive disturbance in severe cases. These signs are not specific enough to select treatment without considering pig age, spread speed, lesions, herd history and laboratory evidence.
The first task is to distinguish clinical disease from exposure or carrier status. Several important swine pathogens can be present without obvious disease, while stress, coinfection or introduction into a naive population can produce an acute outbreak.
This guide supports farm management and product communication. It does not replace laboratory diagnosis or veterinary care. Veterinary medicines must follow approved labels, species indications, withdrawal periods, local regulations and veterinary guidance.
1. Why It Matters
Commercial consequences include mortality in acute cases, chronic poor growth, uneven finishing groups, reproductive loss and repeated treatment cost. The cost is larger than visibly sick pigs because subclinical infection, delayed growth, culling and repeated medication can affect the whole finishing plan.
A reliable investigation separates animal-level treatment from herd-level control. Saving an acute pig is essential, but preventing the same pattern in the next batch requires attention to source status, pig flow, vaccination, environment and carrier animals.
For distributors, professional communication begins with age, number affected, first sign, fever, mortality speed, recent mixing, vaccination, previous medication and sample results. Product selection should follow this information rather than the disease name alone.
2. Pathogen and Risk Factors
1. Mycoplasma suis attaches to red blood cells and can produce immune-mediated hemolytic anemia
Review this factor against the age group, timing, spread, environment, recent movements and response to previous action. Comparing affected and stable pens helps determine whether it is central to the outbreak.
2. Subclinical carrier pigs may show disease after stress, concurrent infection or immunosuppression
Review this factor against the age group, timing, spread, environment, recent movements and response to previous action. Comparing affected and stable pens helps determine whether it is central to the outbreak.
3. Blood transfer through needles, equipment, biting insects or procedures can increase transmission risk
Review this factor against the age group, timing, spread, environment, recent movements and response to previous action. Comparing affected and stable pens helps determine whether it is central to the outbreak.
4. Poor biosecurity and mixing may introduce infected carriers into a stable group
Review this factor against the age group, timing, spread, environment, recent movements and response to previous action. Comparing affected and stable pens helps determine whether it is central to the outbreak.
5. Feed, heat and disease pressure may worsen clinical expression without being the primary cause
Review this factor against the age group, timing, spread, environment, recent movements and response to previous action. Comparing affected and stable pens helps determine whether it is central to the outbreak.
3. Diagnosis and Differentials
PCR is the preferred confirmation tool, while blood smear findings, anemia, clinical history and herd pattern provide supporting evidence. A single negative result may need interpretation with infection stage and sample quality.
Collect samples from untreated, clearly affected pigs whenever possible. The correct tissue or site matters: detection from a normal carrier location may not prove that the organism caused systemic disease.
Differential diagnosis should include diseases producing similar fever, respiratory, neurological, joint, anemia or reproductive signs. Necropsy, histopathology, PCR, culture, serology and antimicrobial susceptibility each answer different questions.
Cases involving severe anemia, collapse, jaundice, high fever, neurological signs, sudden deaths or widespread reproductive problems require prompt veterinary assessment and an emergency response. Suspected zoonotic or notifiable disease also requires appropriate worker protection and local reporting procedures.
4. Treatment and Herd Control
Treatment should target clinically affected pigs early and follow veterinary diagnosis, approved indications and susceptibility information where available. Severely ill pigs may not consume enough medicated water or feed, so the route and timing matter.
Herd control should address introduction routes, carriers, mixing, all-in/all-out flow, vaccination where applicable, stocking density, ventilation, cleaning and drying. Repeated medication without controlling these pressures usually produces an incomplete result.
Because many infections are subclinical, treatment response alone does not confirm M. suis. Reusable needles and blood-contaminated equipment should be included in the transmission review.
5. Related Product Support
Use products in layers: necessary veterinary treatment first, then environment and biosecurity correction, followed by recovery nutrition or feed-safety support where the assessment identifies a need.
Doxycycline HCl Soluble Powder may be considered only when the diagnosed or suspected organism is susceptible and the approved label, withdrawal period, local regulation and veterinarian support its use. This product should not be presented as a universal treatment and must be used within the complete veterinary or nutritional program.
Multivitamin Feed Additive supports micronutrient intake and recovery during periods of reduced appetite, fever, transport or other stress. This product should not be presented as a universal treatment and must be used within the complete veterinary or nutritional program.
Refined Cod Liver Oil Powder (Vitamin AD3E) provides vitamin AD3E nutritional support where it fits the complete ration and approved product use. This product should not be presented as a universal treatment and must be used within the complete veterinary or nutritional program.
Mildew Solution (DCR) – Mycotoxin Binder & Degrader supports feed-safety management when ingredient quality, storage or mycotoxin pressure may be weakening intake and recovery. This product should not be presented as a universal treatment and must be used within the complete veterinary or nutritional program.
These products are not a fixed bundle. Choose only the components relevant to the diagnosed pressure, define the expected response and review the result before extending or changing the program.
6. Farm Prevention
Control introductions and mixing
Know the health status of replacement and feeder pigs, maintain quarantine and avoid combining animals from multiple sources without a herd-health plan.
Reduce daily stress and pathogen load
Maintain ventilation, temperature, stocking, water access, feed quality and all-in/all-out sanitation. Stress does not create the pathogen, but it can change carrier infection into clinical disease.
Use records and diagnostics together
Track age, batch, signs, treatments, mortality, growth and lesion findings. Review repeated cases with the veterinarian so sampling occurs before treatment obscures the result.
7. Application Suggestions and Precautions
Do not combine multiple antimicrobials automatically. More products do not guarantee better control and can increase cost, residues and antimicrobial-resistance pressure. Follow the veterinarian and approved label.
Feed additives support nutrition, recovery or feed safety. They do not diagnose, prevent or cure these infections and do not replace vaccination, biosecurity, clean water, appropriate feed or necessary veterinary treatment.
Keep a written record of the initial condition, actions, dates, products, clinical response and production outcome. A short-lived response suggests that the pathogen source or predisposing pressure remains.
FAQ
Is attached-red-cell disease caused by a parasite?
The current accepted agent is the hemotropic bacterium Mycoplasma suis, formerly Eperythrozoon suis.
Can healthy pigs carry it?
Yes. Subclinical infection can become more important during stress or concurrent disease.
Is a blood smear enough?
It can support suspicion, but PCR improves confirmation and differentiation.
Can vitamins cure M. suis?
No. They support recovery nutrition but do not replace diagnosis and veterinary treatment.
What farm practice deserves attention?
Avoid blood transfer through shared needles or contaminated equipment and review insect control.
References
MSD Veterinary Manual, Hemotropic Mycoplasma Infections in Animals.
MSD Veterinary Manual, Overview of Respiratory Diseases of Pigs.
World Organisation for Animal Health, Responsible and Prudent Use of Antimicrobial Agents in Veterinary Medicine.
